U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
December 08, 2023 at 11:19 AM EST
Casgevy uses Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.
